We describe three cases of sporotrichosis which were successfully treated with itraconazole 100 mg daily. Itraconazole was effective and well tolerated in one patient with lymphocutaneous sporotrichosis who discontinued potassium iodide therapy because of side-effects and in two patients with fixed cutaneous sporotrichosis.
Get full access to this article
View all access options for this article.
References
1.
GrantSClissoldS. Itraconazole—A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in superficial and systemic mycoses. Drugs1989;37:310–44.
RestrepoARobledoJGomezITabaresAGutierrezR. Itraconazole therapy in lymphangitic and cutaneous sporotrichosis. Arch Dermatol1986;122:413–17.
4.
CauwenberghGDegreefHHeykantsJWoestenborghsRVan RooyPHaeveransK. Pharmacokinetic profile of orally administered itraconazole in human skin. J Am Acad Dermatol1988;18:263–8.
